CHG Dressings in Children With Central Lines

Diseases and Conditions Researched

Children With Central Venous Access

What is the purpose of this trial?

The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the number of unscheduled central catheter dressing changes compared to standard clear Tegaderm IV dressing in pediatric patients between the ages of 2 months to 18 years with central venous access. Secondarily, we will monitor contact skin irritation and central line associated blood stream infections.

Participation Guidelines

Age: 2 Months - 18 Years
Gender: Both

This trial accepts healthy volunteers.

Click here for detailed participation information for this trial.

Sponsor: Yale University School of Medicine
Last Updated:
Study HIC#: 1309012748